ABAB Pedia

Jorge Conde

Jorge Conde is a biotechnology entrepreneur and venture capitalist who co-founded the genome interpretation company Knome with George Church and is a general partner on the Bio + Health team at Andreessen HorowitzAndreessen HorowitzAndreessen Horowitz (a16z) is a venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz. It invests from the seed stage through the growth stage and provides operational support to its portfolio companies.Open the full entry (a16z).

Contents7 sections
Key facts

Knome Launches Whole-Genome Sequencing Service

In November 2007, MIT Technology Review reported that Knome had announced a commercial whole-genome sequencing service and identified Conde as the company’s CEO.⁠[2]

Joining Syros Pharmaceuticals

On June 10, 2014, Syros Pharmaceuticals announced that Conde had joined its executive team as chief financial officer and chief product officer, leading platform strategy for its gene regulation technology and overall finances; his most recent role at Knome had been chief financial officer. He later also served as Syros’s chief strategy officer.⁠[1][3]

Knome Is Acquired

According to a16z, Knome was acquired by Tute Genomics in 2015.⁠[4]

Named an a16z General Partner

On June 21, 2017, TechCrunch reported that Andreessen Horowitz was bringing on Conde as a general partner and that he would officially start that September; BuzzFeed News reported that he would invest through the firm’s Bio Fund.⁠[5][3]

As of October 2026: Bio and Health Investing at a16z

As of October 2026, the a16z website describes him as a general partner on the Bio + Health team, investing across therapeutics, diagnostics, tools, and software, and lists his board seats at Asimov, Cartography, Dyno, Earli, Komodo Health, and Octant Bio; he also served on the boards of EQRx, IDRx, and Tmunity through their acquisitions.⁠[4]

Related Organizations, Websites, and Public Accounts

Andreessen Horowitz: Official website: https://a16z.com/ (opens in a new window)⁠[4]

Sources

  1. Syros Pharmaceuticals Appoints Genomics Entrepreneur Jorge Conde to Dual Role as Chief Financial Officer and Chief Product Officer (opens in a new window)
  2. Get Your Genome Sequenced for $350,000 (opens in a new window)
  3. Andreessen Horowitz Is Digging Deeper Into Biotech (opens in a new window)
  4. Jorge Conde (opens in a new window)
  5. Andreessen Horowitz gets a new general partner in Jorge Conde (opens in a new window)